Why the study?
Do refinements in the implantation of pulmonary arterial stents reduce morbidity and mortality in patients with congenital or postoperative pulmonary arterial stenoses?
Population
338 patients undergoing pulmonary arterial stenting between September 1989 and July 2001. Includes patients…
Design
Cohort
Follow-up
mean 5.6 years
Authors
Loading...
Refined pulmonary arterial stenting may improve gradients with negligible recent risk in congenital stenoses; extends observational series but leaves open randomized confirmation.
Do refinements in the implantation of pulmonary arterial stents reduce morbidity and mortality in patients with congenital or postoperative pulmonary arterial stenoses?
Technical and technological refinements in pulmonary arterial stenting over two decades have significantly improved hemodynamics and virtually eliminated procedural morbidity and mortality.
McMahon et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: